Non-invasive Detection of HER2 Expression by Al18F-NOTA-HER2 Affibody in Gastric Cancer Xenografts

被引：0
|
作者：
Han, Jingya [1 ]
Zhao, Xinming [1 ]
Chen, Yang [1 ]
Zhang, Jingmian [1 ]
Wang, Jianfang [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Dept Nucl Med, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1081
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer
    Chen, Ruohua
    Zhou, Xiang
    Liu, Jianjun
    Huang, Gang
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1040 - 1044
  • [22] Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels
    Tolmachev, Vladimir
    Wallberg, Helena
    Sandstrom, Mattias
    Hansson, Monika
    Wennborg, Anders
    Orlova, Anna
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) : 531 - 539
  • [23] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Isabel Pinhel
    Margaret Hills
    Suzanne Drury
    Janine Salter
    Georges Sumo
    Roger A'Hern
    Judith M Bliss
    Ivana Sestak
    Jack Cuzick
    Peter Barrett-Lee
    Adrian Harris
    Mitch Dowsett
    Breast Cancer Research, 14
  • [24] HER2-Targeted Affibody Molecule 99mTc-ABH2 for Imaging HER2 Expression in Breast Cancer
    Jin, Xiaona
    Zhang, Yuwei
    Cao, Xi
    Wang, Peipei
    Ren, Chao
    Cai, Jiong
    Wang, Xuefei
    Jing, Hongli
    Sun, Qiang
    Li, Fang
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : 25 - 30
  • [25] Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels
    Vladimir Tolmachev
    Helena Wållberg
    Mattias Sandström
    Monika Hansson
    Anders Wennborg
    Anna Orlova
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 531 - 539
  • [26] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Pinhel, Isabel
    Hills, Margaret
    Drury, Suzanne
    Salter, Janine
    Sumo, Georges
    A'Hern, Roger
    Bliss, Judith M.
    Sestak, Ivana
    Cuzick, Jack
    Barrett-Lee, Peter
    Harris, Adrian
    Dowsett, Mitch
    BREAST CANCER RESEARCH, 2012, 14 (02)
  • [27] Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings
    Zou, Sijuan
    Liu, Zheng
    Zhou, Jianyuan
    Song, Shuang
    Wang, Dongdong
    Zhu, Dongling
    Cheng, Siyuan
    Cheng, Zhaoting
    Zhu, Yuankai
    Yu, Tianci
    Pan, Donghui
    Yang, Min
    Zhu, Xiaohua
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [28] In vivo PET imaging of HER2 expression with GE226: An 18F-labelled affibody molecule
    Hoppmann, Susan
    Danikas, Antonios
    Durrant, Clare
    Iveson, Peter
    Glaser, Matthias
    Indrevoll, Bard
    Hiscock, Duncan
    CANCER RESEARCH, 2012, 72
  • [29] DETERMINATION OF THE HER2 EXPRESSION IN CHILEAN PATIENTS WITH GASTRIC CANCER
    Painemal, Claudio
    Berrios, Marcela
    Gallegos, Ivan
    San Martin, Carmen
    Villanueva, Luis
    Barajas, Olga
    Ahumada, Monica
    Fuentes, Rodrigo
    ANNALS OF ONCOLOGY, 2012, 23 : 50 - 50
  • [30] Her2 expression in gastric cancer: About forty cases
    Azouz, H. Kamoun
    Khadhar, A.
    Bellil, K.
    Haouet, S.
    Kehir, N.
    VIRCHOWS ARCHIV, 2014, 465 : S141 - S141
12345